Sustained protective immunity against herpes simplex virus type 1 (HSV-1) infection in mice with a glycoprotein D subunit vaccine.

被引：0

|

作者：

Ptak, RG

May, RD

Voss, TG

Marciani, DJ

机构：

[1] So Res Inst, Frederick, MD 21701 USA

[2] So Res Inst, Birmingham, AL 35205 USA

[3] Galenica Pharmaceut Inc, Birmingham, AL 35243 USA

来源：

ANTIVIRAL RESEARCH | 2002年 / 53卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

76

引用

收藏

页码：A58 / A58

页数：1

相关论文

共 50 条

[1] Orofacial herpes simplex virus type 1 (HSV-1) infection in mice: A model for herpes labialis
Palmer, J
Rybak, RJ
Kern, ER
ANTIVIRAL RESEARCH, 2000, 46 (01) : A77 - A77
[2] Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs
Bourne, N
Bravo, FJ
Francotte, M
Bernstein, DI
Myers, MG
Slaoui, M
Stanberry, LR
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (04): : 542 - 549
[3] Mechanisms of herpes simplex virus type 1 (HSV-1) infection of mice brain organotypic cultures
Cohen, Myetal
Braun, Efrat
Panet, Amos
Steiner, Israel
JOURNAL OF NEUROVIROLOGY, 2007, 13 : 72 - 73
[4] Mechanisms of herpes simplex virus type 1 (HSV-1) infection of mice brain organotypic cultures
Steiner, Israel
Braun, Efrat
Cohen, Meytal
Zimmerman, Tal
Panet, Amos
NEUROLOGY, 2007, 68 (12) : A142 - A142
[5] Host Intrinsic and Innate Intracellular Immunity During Herpes Simplex Virus Type 1 (HSV-1) Infection
Alandijany, Thamir
FRONTIERS IN MICROBIOLOGY, 2019, 10
[6] The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge
Frye, TD
Chiou, HC
Hull, BE
Bigley, NJ
ARCHIVES OF VIROLOGY, 2002, 147 (09) : 1747 - 1759
[7] The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge
T. D. Frye
H. C. Chiou
B. E. Hull
N. J. Bigley
Archives of Virology, 2002, 147 : 1747 - 1759
[8] The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice
Augustinova, H
Hoeller, D
Yao, F
JOURNAL OF VIROLOGY, 2004, 78 (11) : 5756 - 5765
[9] Natural history of genital herpes simplex virus type 1 (HSV-1) infection
Wald, A
Engelberg, R
Carrell, D
Corey, L
CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1164 - 1164
[10] Relative therapeutic vaccine efficacy of glycoprotein B and glycoprotein D against recurrent ocular herpes simplex virus type 1 (HSV-1) in lately infected rabbits.
Nesburn, AB
Burke, RL
Slanina, SM
Ghiasi, H
Wechsler, SL
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S57 - S57

← 1 2 3 4 5 →